Note 8 - Long-term Investments

12 Months Ended

Dec. 31, 2024

Notes to Financial Statements

Equity Method Investments and Joint Ventures Disclosure [Text Block]

8. Long-term investment

	Amount
	US$(’000)
Balance as of January 1, 2023		1,596
Exchange translation adjustment		(7	)
Cash investments during the year		64
Disposed during the year		(426	)
Impairment losses provided during the year		(433	)
Balance as of December 31, 2023		794
Cash investments during the year		2
Disposed during the year		(397	)
Impairment losses provided during the year		(2	)
Balance as of December 31, 2024		397

As of December 31, 2024, except for long-term investments which were fully impaired, the Company beneficially owned a 7.69%, 9.9% and 9.9% equity interest in each New Business Holdings Limited (“New Business”), Hunan Yong Fu Xiang Health Management Co., Ltd (“Yong Fu Xiang”) and Wuhan Ju Liang Media Co., Ltd. (“Wuhan Ju Liang”), respectively.

On May 27, 2024, the Company sold approximately 7.69% equity interest in New Business to an unrelated party at a total consideration of approximately US$0.40 million.

The Company measures each investment which does not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the Company.

For the year ended December 31, 2024, the Company provided $0.002 million in impairment loss against its long-term investments.